Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123227223 | 12322722 | 3 | F | 2010 | 20160809 | 20160502 | 20160812 | PER | US-PFIZER INC-2016233424 | PFIZER | 71.00 | YR | F | Y | 0.00000 | 20160812 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123227223 | 12322722 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 10 MG, 1X/DAY | N | 20699 | 10 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 123227223 | 12322722 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | N | 20699 | PROLONGED-RELEASE CAPSULE | ||||||||||
| 123227223 | 12322722 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 123227223 | 12322722 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | UNK (3-125 MG) | 0 | |||||||||||
| 123227223 | 12322722 | 5 | C | NITROFURANTOIN. | NITROFURANTOIN | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 123227223 | 12322722 | 6 | C | LOSARTAN. | LOSARTAN | 1 | (50-12.5) DAILY | 0 | |||||||||||
| 123227223 | 12322722 | 7 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 123227223 | 12322722 | 8 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 0 | ||||||||||||
| 123227223 | 12322722 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
| 123227223 | 12322722 | 10 | C | FISH OIL OMEGA 3 | 2 | UNK | 0 | ||||||||||||
| 123227223 | 12322722 | 11 | C | Vita D | 2 | 1 DF, MONTHLY | 0 | 1 | DF | /month | |||||||||
| 123227223 | 12322722 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | (1,000 DAILY) | 0 | |||||||||||
| 123227223 | 12322722 | 13 | C | ACETAMINOPHEN W/OXYCODONE | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK (OXYCODONE HYDROCHLORIDE 5MG, PARACETAMOL 325MG) | 0 | |||||||||||
| 123227223 | 12322722 | 14 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123227223 | 12322722 | 1 | Depression |
| 123227223 | 12322722 | 2 | Anxiety |
| 123227223 | 12322722 | 7 | Depression |
| 123227223 | 12322722 | 8 | Anxiety |
| 123227223 | 12322722 | 13 | Back pain |
| 123227223 | 12322722 | 14 | Urinary incontinence |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123227223 | 12322722 | Apathy | |
| 123227223 | 12322722 | Asthenia | |
| 123227223 | 12322722 | Drug ineffective | |
| 123227223 | 12322722 | Fatigue | |
| 123227223 | 12322722 | Listless |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123227223 | 12322722 | 5 | 2008 | 0 | ||
| 123227223 | 12322722 | 14 | 2008 | 0 |